Brief: Theravet Launches Pivotal European Multicentric Clinical Study Of Visco-Vet In Canine Osteoarthritis
Sept 10 (Reuters) - THERAVET SA ALVET.PA :
* THERAVET ANNOUNCES THE LAUNCH OF THE PIVOTAL EUROPEAN
MULTICENTRIC CLINICAL STUDY OF VISCO-VET IN CANINE
OSTEOARTHRITIS
* START OF PATIENTS ENROLMENT ANTICIPATED IN OCTOBER 2021
Source text for Eikon: ID:nBwxjSpca
Further company coverage: ALVET.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Theravet SA
See all newsBrief: Theravet Announces Setting Up Of An Equity-Linked Financing Facility
Brief: TheraVet Provides Update On 2023 Half-Year Development And Portfolio Strategy
Brief: Theravet Announces 300% Increase In Participating Centers In Its Osteosarcoma Program
Brief: Theravet End-Dec Cash Position Of EUR 3.19 Mln
Brief: Theravet Signs New Distribution Agreement For Its Biocera-Vet With Elvetis